| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-01-01 FY |
|---|---|---|---|---|
| Revenue | $147.17M | $125.59M | $93.11M | $55.55M |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | – | – | – | – |
| R&D | $195.79M | $322.38M | $338.75M | $329.58M |
| SG&A | $159.10M | $213.86M | $200.27M | $174.11M |
| Operating Income | -$562.16M | -$2.19B | -$1.52B | -$5.44B |
| Interest Expense | – | – | – | – |
| Tax Expense | -$126.15M | -$135.36M | -$41.95M | -$42.29M |
| Net Income | -$408.35M | -$2.03B | -$1.47B | -$5.40B |
| EPS (basic) | -11.1100 | -63.5400 | -47.2100 | -173.8900 |
| EPS (diluted) | -11.1100 | -63.5400 | -47.2100 | -173.8900 |
| Shares (diluted) | $36.75M | $31.90M | $31.05M | $31.05M |